These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 20397948)
41. XDR Tuberculosis: a report from the New Delhi Tuberculosis Centre, India. Dhingra VK; Malik S; Hanif M; Arora VK J Coll Physicians Surg Pak; 2009 Feb; 19(2):133-5. PubMed ID: 19208323 [No Abstract] [Full Text] [Related]
42. Multidrug resistant tuberculosis: a growing public health threat. Salahuddin N J Coll Physicians Surg Pak; 2009 Sep; 19(9):537-8. PubMed ID: 19728935 [No Abstract] [Full Text] [Related]
43. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213 [TBL] [Abstract][Full Text] [Related]
44. Rapid culture-based methods for drug-resistance detection in Mycobacterium tuberculosis. Palomino JC; Martin A; Von Groll A; Portaels F J Microbiol Methods; 2008 Oct; 75(2):161-6. PubMed ID: 18627779 [TBL] [Abstract][Full Text] [Related]
45. First- and second-line drug resistance patterns among previously treated tuberculosis patients in India. Paramasivan CN; Rehman F; Wares F; Sundar Mohan N; Sundar S; Devi S; Narayanan PR Int J Tuberc Lung Dis; 2010 Feb; 14(2):243-6. PubMed ID: 20074419 [TBL] [Abstract][Full Text] [Related]
46. The significance of GlgE as a new target for tuberculosis. Kalscheuer R; Jacobs WR Drug News Perspect; 2010 Dec; 23(10):619-24. PubMed ID: 21180647 [TBL] [Abstract][Full Text] [Related]
47. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend. Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382 [TBL] [Abstract][Full Text] [Related]
48. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Moss AR; Alland D; Telzak E; Hewlett D; Sharp V; Chiliade P; LaBombardi V; Kabus D; Hanna B; Palumbo L; Brudney K; Weltman A; Stoeckle K; Chirgwin K; Simberkoff M; Moghazeh S; Eisner W; Lutfey M; Kreiswirth B Int J Tuberc Lung Dis; 1997 Apr; 1(2):115-21. PubMed ID: 9441074 [TBL] [Abstract][Full Text] [Related]
49. [New tuberculosis drugs in resistant and multiresistant tuberculosis]. Ramírez Lapausa M; Pascual Pareja JF; Noguerado Asensio A Med Clin (Barc); 2013 Oct; 141(7):306-13. PubMed ID: 23540388 [TBL] [Abstract][Full Text] [Related]
50. [Drug-resistant tuberculosis: resistance mechanisms and drug susceptibility of Mycobacterium tuberculosis]. Katalinić-Janković V; Obrovac M Acta Med Croatica; 2004; 58(4):323-8. PubMed ID: 15700689 [TBL] [Abstract][Full Text] [Related]
51. Initial drug resistance pattern in new cases of pulmonary tuberculosis. Chandramuki A; Nagarathna S; Veena Kumari HB; Buggi S J Assoc Physicians India; 2008 Mar; 56():202. PubMed ID: 18697641 [No Abstract] [Full Text] [Related]
52. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool. Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438 [TBL] [Abstract][Full Text] [Related]
53. [Extensively drug-resistant tuberculosis (XDR-TB): successful therapies used in the clinic to the disease]. Llamas-González YY; Flores-Valdez MA Rev Invest Clin; 2013; 65(3):255-62. PubMed ID: 23877813 [TBL] [Abstract][Full Text] [Related]
54. Totally drug resistant tuberculosis--a fact or myth? Behera D Indian J Tuberc; 2012 Oct; 59(4):190-3. PubMed ID: 23342538 [No Abstract] [Full Text] [Related]
55. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]. Yoshiyama T; Ogata H; Ito K; Aono A; Wada M Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318 [TBL] [Abstract][Full Text] [Related]
56. The prevalence of Mycobacterium tuberculosis drug resistance in New Caledonia, 1995-1996. Duval P; Levenes H; Boulahbal F Int J Tuberc Lung Dis; 1999 Mar; 3(3):219-23. PubMed ID: 10094323 [TBL] [Abstract][Full Text] [Related]
57. inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa? Müller B; Streicher EM; Hoek KG; Tait M; Trollip A; Bosman ME; Coetzee GJ; Chabula-Nxiweni EM; Hoosain E; Gey van Pittius NC; Victor TC; van Helden PD; Warren RM Int J Tuberc Lung Dis; 2011 Mar; 15(3):344-51. PubMed ID: 21333101 [TBL] [Abstract][Full Text] [Related]
58. Drug resistance in Mycobacterium tuberculosis isolates from tuberculosis patients in Kerala, India. Joseph BV; Soman S; Radhakrishnan I; Madhavilatha GK; Paul LK; Mundayoor S; Kumar RA Int J Tuberc Lung Dis; 2009 Apr; 13(4):494-9. PubMed ID: 19335956 [TBL] [Abstract][Full Text] [Related]
59. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis. Schaaf HS; Willemse M; Donald PR Pediatr Infect Dis J; 2009 Aug; 28(8):748-50. PubMed ID: 19633523 [TBL] [Abstract][Full Text] [Related]
60. Extensively drug-resistant tuberculosis: is its definition correct? Caminero JA Eur Respir J; 2008 Nov; 32(5):1413-5. PubMed ID: 18978145 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]